Related Experiment Video
Updated: Jul 10, 2025

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.4K
MiRNA-Responsive CRISPR-Cas System via a DNA Regulator.
1Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
Biosensors
|November 24, 2023
Summary
Researchers developed a novel CRISPR activation system regulated by microRNAs (miRNAs). This simple system allows for controlled gene editing by releasing CRISPR-associated protein 9 (Cas9) activity upon miRNA binding.
Area of Science:
- Molecular Biology
- Biotechnology
- Genetics
Background:
- Clustered regularly interspaced short palindromal repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) is a versatile genome editing tool.
- Existing methods for regulating CRISPR-Cas9 activity often involve complex engineering.
- There is a need for simple and convenient regulatory systems for CRISPR-Cas9 technology.
Purpose of the Study:
- To devise a simple and convenient CRISPR activation system regulated by microRNAs (miRNAs).
- To create a DNA regulator that can be activated by specific miRNAs, thereby controlling CRISPR-Cas9 activity.
Main Methods:
- Designed a DNA regulator with two components: an inhibition component (PAM and seed sequence) that binds to the Cas9-ribonucleoprotein (RNP) complex, and an miRNA recognition component.
- The miRNA recognition component features a toehold DNA for target miRNA binding and a partially double-stranded DNA for miRNA complementarity.
- Upon binding of target miRNAs, the regulator's structure is disrupted, leading to its dissociation from the RNP complex and restoration of CRISPR activity.
Main Results:
- The developed system successfully demonstrated miRNA-activated regulation of CRISPR-Cas9 activity.
- The DNA regulator effectively inhibited Cas9-RNP complex activity until target miRNA binding occurred.
- The system showed potential for application to various miRNAs through simple sequence modifications.
Conclusions:
- This study presents a general and adaptable platform for controlled genome editing using a miRNA-activated CRISPR system.
- The developed system offers a simple and convenient method for regulating CRISPR-Cas9 activity.
- This approach facilitates precise genetic manipulation by enabling miRNA-specific control over genome editing processes.
More Related Videos
Related Concept Videos
CRISPR
51.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.8K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K
Cis-regulatory Sequences
9.9K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
9.9K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K

